LimmaTech Biologics
PrivateLast Round
Grant
Feb 17, 2025
Total Funding Raised
$48.7M
Company Overview
LimmaTech Biologics is a biopharmaceutical company dedicated to the research, development, and production of innovative bioconjugate vaccines that enhance the prevention of life-threatening diseases through advanced glycoengineering techniques.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LimmaTech Biologics Comps
Public and private peers based on sector, stage, and business model.
LimmaTech Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 17, 2025 | ||||
| Grant | Feb 27, 2024 | ||||
| Series A Extension | Feb 1, 2024 | ||||
| Series A | Oct 9, 2023 |
Key People
Founding team and executive leadership
LimmaTech Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| REPAIR Impact Fund | Series A |
| CARB-X | Grant |
| AXA IM Alts | Series A Extension, Series A |
| AXA Investment Managers | Series A |
| Adjuvant Capital | Series A Extension, Series A |
| Tenmile | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 10, 2025
Partnering with Valneva to co-develop S4V2 vaccine.
- Apr 10, 2025
Partnering with Valneva to develop the S4V2 vaccine for Shigella.
LimmaTech Biologics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about LimmaTech Biologics's valuation, stock price, and market status.
